High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer

Due to the lack of specific targets, cytotoxic chemotherapy still represents the common standard treatment for triple-negative breast patients. Despite the harmful effect of chemotherapy on tumor cells, there is evidence that treatment could modulate the tumor microenvironment in a way favoring the...

Full description

Bibliographic Details
Main Authors: Sandra Torres-Ruiz, Eduardo Tormo, Iris Garrido-Cano, Ana Lameirinhas, Federico Rojo, Juan Madoz-Gúrpide, Octavio Burgués, Cristina Hernando, Begoña Bermejo, María Teresa Martínez, Ana Lluch, Juan Miguel Cejalvo, Pilar Eroles
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:International Journal of Molecular Sciences
Subjects:
VEGFR3
triple-negative breast cancer
doxorubicin
Online Access:https://www.mdpi.com/1422-0067/24/4/3601

Internet

https://www.mdpi.com/1422-0067/24/4/3601

Similar Items